Arcutis director granted RSUs and stock options
Arcutis Biotherapeutics, Inc. director Amit Munshi reported equity awards tied to his service as a non-employee director.
Rhea-AI Filing Summary
Arcutis Biotherapeutics, Inc. director Amit Munshi reported equity awards tied to his service as a non-employee director. He received 5,778 Restricted Stock Units that convert into an equal number of common shares when they vest. After this grant, he holds 9,799 common shares directly.
Munshi also received a stock option for 16,667 shares of common stock at an exercise price of $21.23 per share. Both the RSUs and the option vest 100% on the earlier of the first anniversary of the June 5, 2026 grant date or immediately before the next annual meeting of stockholders, subject to continued service through the vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,445 shares
Grant/Award
2 txns
Insider
Munshi Amit
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 16,667 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,778 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 16,667 contracts (Direct);
Common Stock — 9,799 shares (Direct)
Footnotes (2)
- F1. Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
- F2. The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
Key Figures
RSUs granted: 5,778 RSUs
Common shares after grant: 9,799 shares
Stock options granted: 16,667 options
+3 more
6 metrics
RSUs granted
5,778 RSUs
Granted as of 2026 annual meeting for non-employee director service
Common shares after grant
9,799 shares
Total Arcutis common stock held directly after RSU award
Stock options granted
16,667 options
Right to buy Arcutis common stock under new option award
Option exercise price
$21.23 per share
Exercise price for 16,667-share stock option grant
Option expiration
June 5, 2036
Expiration date of the stock option grant
Vesting date reference
June 5, 2026
First anniversary used to determine vesting for RSUs and option
Key Terms
Restricted Stock Units ("RSUs"), non-employee director, annual meeting of stockholders, stock option
4 terms
Restricted Stock Units ("RSUs") financial
"Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
non-employee director financial
"granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting"
annual meeting of stockholders financial
"as of the Company's 2026 annual meeting of stockholders"
stock option financial
"The underlying shares subject to the option vest and become exercisable as to 100%"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What did Amit Munshi acquire in this Arcutis (ARQT) Form 4 filing?
Amit Munshi received equity awards consisting of 5,778 RSUs and a stock option for 16,667 shares of Arcutis common stock. These awards were granted as compensation for his service as a non-employee director.
What is the exercise price of Amit Munshi’s new stock options in Arcutis (ARQT)?
The stock option granted to Amit Munshi has an exercise price of $21.23 per share. This means he can buy up to 16,667 Arcutis common shares at $21.23 each once the option vests and is exercisable.
When do Amit Munshi’s RSUs and stock options in Arcutis (ARQT) vest?
Both the 5,778 RSUs and the 16,667-share stock option vest 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting, subject to continued service.
Are Amit Munshi’s new Arcutis (ARQT) awards part of director compensation?
Yes. The filing states the RSUs and stock option were granted in connection with Amit Munshi’s service as a non-employee director as of Arcutis’ 2026 annual meeting of stockholders, reflecting standard equity-based board compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
